Let’s dig into the relative performance of Genuine Parts (NYSE:GPC) and its peers as we unravel the now-completed Q4 auto parts retailer earnings season.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Ameris Bancorp (NYSE:ABCB) and the rest of the regional banks stocks fared in Q4.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the asset management industry, including TPG (NASDAQ:TPG) and its peers.

Kraft Heinz is still facing many tough challenges.

Wall Street is approaching the end to a contentious earnings season defined by an AI sell-off.

Wall Street is approaching the end to a contentious earnings season defined by an AI sell-off.

The PCE inflation reading for December is the highlight in a heavy slate of economic data.

The PCE inflation reading for December is the highlight in a heavy slate of economic data.

Meta reduced its annual distribution of stock options by ‌about 5% for most of ‌its staff, as CEO Mark Zuckerberg ploughs billions ​of dollars into its artificial intelligence goals, the Financial Times reported on Thursday. The Facebook parent did not i

It’s a strong market, but will it stick around? This month’s question for the State of Freight webinar. The post State of Freight five takeaways: a strong market likely sticking around appeared first on FreightWaves.

Specialty insurance company Hamilton Insurance Group (NYSE:HG) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 27.7% year on year to $728.3 million. Its non-GAAP profit of $1.65 per share was 56.4% above analysts’ consensus estimates.

OLED provider Universal Display (NASDAQ:OLED) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.6% year on year to $172.9 million. On the other hand, the company’s full-year revenue guidance of $675 million at the midpoint came in 6.3%

Medical device company ICU Medical (NASDAQ:ICUI) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales fell by 13% year on year to $540.7 million. Its non-GAAP profit of $1.91 per share was 12.8% above analysts’ consensus estimates.

Medical technology company iRhythm Technologies (NASDAQ:IRTC) announced better-than-expected revenue in Q4 CY2025, with sales up 27.1% year on year to $208.9 million. The company’s full-year revenue guidance of $875 million at the midpoint came in 0.6% ab

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 15% year on year to $290.4 million. Its GAAP loss of $0.01 per share was 84.4% above analysts’ consensus estimates.